The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing-Reference-Cited by-同舟云学术

The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing

Published:2021 Issue:1-2 Volume:86 Page:123-131
ISSN:0378-7346
Container-title:Gynecologic and Obstetric Investigation
language:en
Short-container-title:Gynecol Obstet Invest

Author:

Qu Shoufang,Zhang Yanyan,Yang Xin,Tan Yueqiu,Li Ming,Yang Xuexi,Zhou Lijun,Chen Di,Chen Yangyi,Yan Miaoli,Wang Qiwei,Yu Ting,Sun Nan,Jiang Hui,Su Fengxia,Di Yufen,Lin Ge,Yuan Yuying,Chen Fang,Mu Feng,Huang Jie^ORCID

Abstract

Introduction: The sequencing-based noninvasive prenatal testing (NIPT) has been successfully integrated into clinical practice and facilitated the early detection of fetal chromosomal anomalies. However, a comprehensive reference material to evaluate and quality control NIPT services from different NIPT providers remains unavailable. Methods: In this study, we established a set of NIPT reference material consisting of 192 simulated samples. Most of the potential factors influencing the accuracy of NIPT, such as fetal fraction, mosaicism, and interfering substances, were included in the reference material. We compared the performance of chromosomal abnormalities detection on 3 widely used sequencers (NextSeq 500, BGISEQ-500, and Ion Proton) based on the reference material. Results: All 3 sequencers provided highly accurate and reliable results to samples with ≥3.5% fetal fractions and high percentage of mosaicism. Conclusions: The established reference material can serve as a universal standard quality control for the current and new-coming NIPT providers based on various sequencers.

Publisher

S. Karger AG

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference33 articles.

1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–7.

2. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008;105(42):16266–71.

3. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med. 2011;13(11):913–20.

4. Dan S, Wang W, Ren J, Li Y, Hu H, Xu Z, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn. 2012;32(13):1225–32.

5. Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302–14.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordant performances of non-invasive prenatal testing for foetal trisomy 21 screening in subgroups of pregnancies;Journal of Obstetrics and Gynaecology;2023-12-06

2. Focus on the frontier issue: progress in noninvasive prenatal screening for fetal trisomy from clinical perspectives;Critical Reviews in Clinical Laboratory Sciences;2023-01-16

3. Efficiency of Noninvasive Prenatal Testing for Sex Chromosome Aneuploidies;Gynecologic and Obstetric Investigation;2021